BIO-MAR Diagnostics

What BIO-MAR Diagnostics does

BIO-MAR Diagnostyka Sp. z o.o. is a Polish medical diagnostic products distributor founded in 2001 and headquartered in Gliwice, Silesia. The company distributes reagent kits for in vitro diagnostics and laboratory automation equipment from leading international manufacturers, primarily Aesku Diagnostics (Germany), Virion Serion, Spinreact, and Zhuhai Keyu Biological Engineering (China). Its product portfolio spans parasitological stool analysis (automated analyzers KU-F600, KU-F40, FI-620), autoimmunology (AESKULISA ELISA tests harmonized through the AESKU.ONE concept), allergology (AlleisaScreen immunoblot panels), urinalysis, infections, clinical chemistry, coagulation, electrolytes, rapid tests, Borrelia diagnostics, and COVID-19 testing.

The business model is B2B sales-led, targeting medical diagnostic laboratories, hospitals, clinics, and medical practices across Poland through dedicated customer service, public procurement, logistics, and accounting departments. The firm holds NFZ (National Health Fund) reimbursement eligibility for its allergy diagnostics, enabling integration into Polish public healthcare purchasing. It generates revenue primarily through distribution margins on hardware and reagent sales, supplemented by a newsletter-driven customer retention program offering 15% discounts on repeat orders.

BIO-MAR operates from a single headquarters location with 8 employees, focuses exclusively on the Polish market (with concentration in the Silesia region), and has no disclosed parent company, external investors, M&A activity, or funding history. The company is privately held with no publicly traded shares.

Name

BIO-MAR Diagnostics

Legal name

BIOMAR DIAGNOSTYKA Sp. z o.o.

Website

https://bio-mar.com.pl

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

BIO-MAR Diagnostyka is a Polish medical diagnostic product distributor founded in 2001, supplying reagent kits and laboratory automation equipment from international manufacturers to medical laboratories, hospitals, and clinics across Poland.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics Distribution

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• In vitro diagnostics distribution
• Medical laboratory reagents
• Laboratory automation equipment
• Parasitological diagnostics
• Autoimmunology diagnostics

Headquarters

HQ city

Gliwice

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Diagnostic Product Distribution: Distribution of diagnostic reagent kits and laboratory equipment to medical laboratories and healthcare facilities. Revenue generated from product sales with dedicated public procurement department for government healthcare contracts.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

BIO-MAR Diagnostyka distributes diagnostic reagent kits and laboratory automation equipment from world-leading manufacturers (Aesku Diagnostics, Virion Serion, Spinreact, and Zhuhai Keyu Biological Engineering) to medical diagnostic laboratories and healthcare facilities in Poland. The portfolio covers in vitro diagnostics for stool analysis, urine analysis, autoimmunology, infections, allergology, clinical chemistry, coagulation, electrolytes, COVID-19, and rapid tests, including the AESKU.ONE harmonized ELISA system and automated stool/FIT analyzers.

Product overview

BIO-MAR Diagnostics is a distributor of diagnostic products from leading world manufacturers (Aesku Diagnostics, Virion Serion, Spinreact, Zhuhai Keyu). Their portfolio centers on laboratory diagnostic solutions including automated stool analyzers (KU-F600, KU-F40, FI-620) for parasitological and gastrointestinal screening diagnostics, AESKULISA® ELISA tests with the AESKU.ONE harmonization system for autoimmunology, AlleisaScreen® immunoblot allergy panels, Borrelia diagnostic tests, and a comprehensive range covering urinalysis, infections, clinical chemistry, coagulation, electrolytes, rapid tests, and COVID-19 diagnostics. The company offers both reagent kits and laboratory equipment for automation.

Differentiator

Problem solved

Functional benefit

Products and services

• AESKULISA Tests with AESKU.ONE Comprehensive autoimmunology test system utilizing the AESKU.ONE concept for harmonized ELISA diagnostics, covering rheumatology, gastroenterology, hepatology, diabetes, thyroid, thrombosis, vasculitis, and Lyme disease testing. Distributed for Aesku Diagnostics.
• AlleisaScreen Allergy Panels Allergen panels for respiratory (30 RESP LVN) and food (30 FOOD LVN) allergy testing using immunoblot methodology to detect allergen-specific IgE antibodies in human serum or plasma. NFZ (National Health Fund) reimbursable in Poland.
• KU-F600 Stool Analyzer Compact automated stool analyzer for routine parasitological and biochemical analysis using sedimentation methodology, suitable for standard laboratory throughput. Manufactured by Zhuhai Keyu Biological Engineering.
• KU-F40 Stool Analyzer High-capacity automated stool analyzer for laboratories with higher throughput requirements, utilizing sedimentation methodology for parasitological diagnostics. Manufactured by Zhuhai Keyu Biological Engineering.
• FI-620 Immunofluorescence Analyzer Quantitative immunofluorescence analyzer for FIT (Fecal Immunochemical Test) screening and calprotectin testing in gastrointestinal disease diagnostics, compliant with national consultant opinions on FIT-OC testing. Manufactured by Zhuhai Keyu Biological Engineering.
• Borrelia Diagnostic Tests (Aeskulisa B. burgdorferi) ELISA screening test and Western Blot confirmatory test for Borrelia burgdorferi and other Borrelia strains, enabling a two-step diagnostic protocol for Lyme disease. Distributed from Aesku Diagnostics.
• Rapid Tests Rapid diagnostic tests for point-of-care testing applications.
• COVID-19 Diagnostic Tests Quantitative and qualitative tests for SARS-CoV-2 diagnostics distributed by BIO-MAR in Poland.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Aesku DiagnosticscoreTechnology or IntegrationGerman manufacturer of autoimmunology diagnostic products including AESKULISA ELISA tests and borreliosis diagnostics (ELISA screening and Western Blot confirmation tests). AESKU.ONE concept developed for harmonized laboratory diagnostics.
• Virion SerioncoreTechnology or IntegrationWorld-leading manufacturer of diagnostic products distributed by BIO-MAR in Poland.
• SpinreactcoreTechnology or IntegrationWorld-leading manufacturer of diagnostic products distributed by BIO-MAR in Poland.
• Zhuhai Keyu Biological Engineering Co., Ltd.coreTechnology or IntegrationManufacturer of automated stool analyzers (KU-F600, KU-F40) using sedimentation method and FI-620 immunofluorescence analyzer for FIT tests. Single manufacturer for all stool analyzers enabling consistent technology implementation.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Siemens Healthineers Poland: Polish operations of Siemens Healthineers covering IVD, including clinical chemistry, immunoassay, and coagulation analyzers. Comparable as a broad-line incumbent bidder on Polish public hospital tenders.
• bioMérieux Poland: Subsidiary of global IVD leader bioMérieux, operating direct sales in microbiology, infectious disease, and industrial diagnostics across Polish hospital and lab customers. Comparable as a major IVD presence competing in Polish clinical labs.
• Roche Diagnostics Poland: Direct Polish operations of Roche Diagnostics, covering clinical chemistry, immunoassays, and molecular diagnostics. Comparable as a broad-line incumbent competing for the same hospital lab budgets BIO-MAR's reagents address.
• Abbott Diagnostics Poland: Polish arm of Abbott's diagnostics division, distributing immunoassays, clinical chemistry, and point-of-care across Polish healthcare facilities. Comparable as an international IVD incumbent competing for Polish lab share.

Direct peers

• DiaSys Diagnostic Systems: German manufacturer of clinical chemistry reagents and automated analyzers sold through regional distributors. Comparable as a mid-sized IVD specialist distributed in Central Europe with similar reagent-plus-analyzer bundling.
• PZ Cormay: Polish diagnostics company that develops, manufactures, and distributes clinical chemistry reagents and analyzers. Directly comparable as a Polish-headquartered IVD reagent and equipment distributor serving hospital and clinical labs.
• DRG Medtek: European IVD distributor serving Central and Eastern European markets with specialty endocrine and autoimmune diagnostics. Comparable as a regional specialty distributor with a multi-vendor reagent portfolio.

Emerging players

• ALPCO Diagnostics: US-based specialty IVD distributor with growing European footprint, focused on immunoassay kits for endocrinology, gastroenterology, and autoimmune research applications. Comparable as a smaller specialty reagent distributor with overlapping test menu.
• Euroimmun (Revvity / PerkinElmer): Autoimmunity-focused diagnostics specialist now operating under Revvity/PerkinElmer. Comparable as a niche IVD reagent and instrument vendor serving the same autoimmunology labs BIO-MAR targets.

Regional players

• Sysmex Poland: Polish subsidiary of Sysmex, focused on hematology and urinalysis analyzers sold to Polish clinical labs. Comparable as a regional IVD distributor with overlapping product breadth in routine diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BioMarDiagnostyka
• LinkedInlinkedin.com/company/bio-mar-diagnostyka

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIO-MAR Diagnostics